School of Medicine
Showing 51-100 of 535 Results
-
Tom Wandless
Professor of Chemical and Systems Biology
Current Research and Scholarly InterestsWe employ an interdisciplinary approach to studies of biological systems, combining synthetic chemistry with biochemistry, cell biology, and structural biology. We invent tools for biology and we are motivated by approaches that enable new experiments with unprecedented control. These new techniques may also provide a window into mechanisms involved in maintaining cellular homeostasis. Protein quality control is a particular interest at present.
-
Adam Wang
Assistant Professor of Radiology (Radiological Sciences Laboratory)
BioMy research group develops technologies for advanced x-ray and CT imaging, including artificial intelligence for CT acquisition, reconstruction, and image processing; spectral imaging, including photon counting CT (PCCT) and dual-layer flat-panel detectors; novel system and detector designs; and their applications in diagnostic imaging and image-guided procedures. I am also the Director of the Photon Counting CT Lab, Zeego Lab, and Tabletop X-Ray Lab.
I completed my PhD in Electrical Engineering at Stanford, developing strategies for maximizing the information content of dual energy CT and photon counting detectors. I then pursued a postdoctoral fellowship at Johns Hopkins in the I-STAR Lab, developing reconstruction and registration methods for x-ray based image-guided surgery. I was then a Senior Scientist at Varian Medical Systems, developing x-ray/CT methods for image-guided radiation therapy, before returning to Stanford in 2018, where I now lead a comprehensive research program in advanced x-ray and CT imaging systems and methods, with funding from NIH, DOD, DOE, and industry partners. -
Aileen Xinqian Wang
Clinical Assistant Professor, Medicine - Nephrology
BioPhilosophy of Care: dedicated to clear communication and teamwork approach to provide the best care possible to all patients.
Clinical Interests: focus on individualized evaluation/tailoring of clinical immunosuppression, management of mineral bone disease post kidney transplant, and the prevention/treatment of COVID-19 in kidney transplant recipients.
Research/Academic Interests: focus on optimization of immunosuppression regimen, mineral bone disease in kidney transplant recipients, delayed graft function outcomes, and COVID-19 infection in kidney transplant recipients. -
Bing Wang
Postdoctoral Scholar, Stem Cell Transplantation
BioMy academic training and research experience have equipped me with multidisciplinary skills and knowledge of molecular biology and immunology.
I led two projects when I was an undergraduate, in which I got primary academic learning. My team member and I investigated the bacteria content in drinking water from two types of machines that are commonly used in colleges under the guidance of our experimental microbiology teacher Zhihong Zhong. Secondly, we produced a hybridoma cell line secreting monoclonal antibody against the core antigen of the hepatitis C virus (HCV) to develop an ELISA kit for the detection of HCV under the guidance of Dr. Rushi Liu and Minjing Liao.
Thereafter, as a Ph. D. candidate at Xiaoming Feng’s lab, my research primarily focused on understanding the biology of regulatory T cells (Treg) and CD11c+ myeloid cells using cutting-edge single-cell sequencing and conditional knockout mice under healthy and disease conditions. We first revealed the heterogeneity and bifurcated differentiation pathway of human Tregs from normal donors and transplanted patients at the single-cell transcriptome level. A subsequent first and corresponding author publication identified a key innate responsive protein in CD11c+ alveolar macrophages, NRP2, that protects mice from lung injury via promoting the phagocytosis of neutrophils. I also participated in two projects regarding the role of a serine/threonine kinase, LKB1, in mice CD11c+ dendritic cells from lymphoid tissues and adipose tissue with diet-induced obesity. These academic experiences guided me into a strong passion and independent capacities for biomedical studies.
For my postdoctoral training, I will focus on developing Treg therapies and genetic stem cell therapy to cure patients with IPEX syndrome (a severe autoimmune disease) at preclinical and clinical stages, and other immune disorders. My sponsor Dr. Rosa Bacchetta is a well-known leader in treating IPEX patients and developing Treg therapies. My co-mentor Dr. Maria Grazia Roncarolo is a well-recognized pediatric immunologist and also one of the pioneers in the stem cell and gene therapy field, who discovered the type 1 regulatory T cells or Tr1 cells and translate the scientific discoveries into novel Treg therapies. Both of them have an excellent record of training postdoctoral fellows. The proposed projects will provide me with great opportunities in cutting-edge technology and translational research and outline a set of career development including grant writing, public presentation, and lab management, which will enhance my ability to become an independent investigator and help me to reach my goal of developing efficient and safe Treg therapies for a wide range of immune disorders and associated human diseases. -
Bo Wang
Associate Professor of Bioengineering and, by courtesy, of Developmental Biology
Current Research and Scholarly InterestsResearch interests:
(1) Systems biology of whole-body regeneration
(2) Cell type evolution through the lens of single-cell multiomic sequencing analysis
(3) Quantitative biology of brain regeneration
(4) Regeneration of animal-algal photosymbiotic systems -
Chen Wang, MD, PhD
Clinical Assistant Professor, Dermatology
BioDr. Wang is a board-certified dermatologist with the Stanford Dermatology Clinic and a clinical assistant professor in the Department of Dermatology at Stanford University School of Medicine.
Dr. Wang specializes in medical dermatology. He commonly diagnoses and treats conditions such as acne, inflammatory skin diseases, hair loss, and skin cancer.
Dr. Wang completed a postdoctoral fellowship in immunology research with the Mark M. Davis Laboratory at Stanford University. His research interests include cutaneous immunology and the role of T cells in inflammatory skin diseases. -
C. Jason Wang, MD, PhD
LCY: Tan Lan Lee Professor and Professor of Pediatrics (General Pediatrics) and of Health Policy
BioDr. Wang is the Director of Center for Policy, Outcomes and Prevention. Prior to coming to Stanford in 2011, he was a faculty member at Boston University Schools of Medicine and Public Health. His other professional experiences include working as a management consultant with McKinsey and Company and serving as the project manager for Taiwan's National Health Insurance Reform Task-force. His current interests include: 1) pandemic preparedness; 2) role of generative Ai on child health and development; 3) use of mobile technology in improving quality of care; 4) assessing and improving the value of healthcare, and 5) healthcare delivery innovations and payment reforms.
-
Ellen Wang
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Professor, Clinical InformaticsBioEllen Wang, MD is a Clinical Associate Professor of Pediatric Anesthesiology and Medical Director of Clinical Informatics for Perioperative Services at Lucile Packard Children’s Hospital Stanford. She is board-certified in Pediatric Anesthesiology and Clinical Informatics, with particular emphasis on EHR enhancement and optimization projects that support surgical, nursing, and pediatric and obstetric anesthesia workflows. She is also Chief of Operations of the Stanford Chariot Program, combining her interest in clinical care, process improvement, data analytics and research with virtual/augmented reality technologies to advance and evolve standards in patient care.
-
Gordon Wang
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioGordon Wang received his Bachelors of Arts and Science from the University of California, Davis in 2000 majoring in Comparative literature and Genetics. He received his PhD under Dr. Mu-ming Poo at the University of California, Berkeley in 2005 studying the role of ion channels in mediating neuronal growthcone guidance decisions. As a postdoctoral scholar in the lab of Dr. Stephen Smith at Stanford University, Gordon developed a computational architecture for the detailed study of molecular diversity in synapses and using this system, he studied the diverse role of synaptic diversity in neurodevelopmental diseases, such as fragile x syndrome. In a co-postdoc in Dr. Philippe Mourrain's lab, he studied the dynamic plasticity of synapses in sleep and circadian cycles in larval zebrafish using multi-photon microscopy. The Wang lab focuses on developing imaging tools to deeply analyze proteins, mRNA and lipids at the synapses, and understand how synaptic heterogeneity affect the function of neural circuits throughout development and aging and in diseases such as autism and fragile x syndrome.
-
Haojie Wang
Postdoctoral Scholar, Medicine
BioHi, I am a Postdoctoral Fellow at Stanford Data Science, with a joint appointment at School of Medicine. I am interested in using insights from data science and remote sensing to address the challenges of sustainable development. I develops GeoAI approaches for detecting labor trafficking in supply chains, population health monitoring, natural hazard forecasting, and advancing understanding of how environmental risks interact with human health.
-
Jack Tzu-Chieh Wang, MD, PhD
Instructor, Adult Neurology
Current Research and Scholarly InterestsOur primary research focus is understanding the molecular mechanisms of axonal degeneration and subsequent failure of axonal regeneration in the CNS. We have identified critical cellular pathways mediating axonal degeneration following acute neurological injuries including ischemic stroke and traumatic brain injury. Modulating these pathways presents a novel therapeutic strategy to protect vulnerable nerve fibers and enhance functional recovery in a multitude of acute CNS injuries and diseases.
-
Jennifer Y. Wang, MD
Clinical Assistant Professor, Dermatology
BioDr. Wang is a board-certified dermatologist. She is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. Dr. Wang is also board-certified in dermatopathology.
Her clinical interests include medical dermatology and cutaneous oncology, including melanoma, high-risk skin cancer, and cutaneous lymphoma. Her research interests include the histopathologic characterization of rare skin disorders and improving the detection and treatment of skin cancers. -
Jie Wang
Postdoctoral Scholar, Radiology
BioDr. Jie Wang is deeply passionate about magnetic nanotechnology, including magnetic resonance imaging (MRI), magnetic particle imaging (MPI), magnetic nanoparticles (MNPs), magnetic nanofluid hyperthermia (MNFH), magnetic biosensors, etc., for biomedical applications. His dissertation focuses on MRI-guided magnetic hyperthermia for cancer theranostics. Currently, his research interests include developing enzyme-activable nanoparticles for brain cancer theranostics and employing multi-modal imaging modalities to investigate the interaction between nanoparticles and biosystems (nano-bio interaction) within tumor microenvironment.
-
Lei Wang
Clinical Professor, Radiation Oncology - Radiation Physics
BioLei Wang, PHD, DABR, is a clinical professor in the Department of Radiation Oncology at Stanford, motivated in advancing patient quality of care, improving education for residents and trainees, and conducting clinical research to improve the quality and accuracy in treatment delivery. She is an expert in CyberKnife SRS/SBRT with more than 15 years of experiences. She currently serves as the chair of the AAPM task group 135.B committee on quality assurance for robotic radiosurgery.
Research interest: small field dosimety, machine and patient quality assurance, treatment planning, etc; new QA tool and methodology development; new treatment technology implementation to keeping high standard in patient care. -
Li Wang
Assistant Professor of Biology
BioLi is a developmental neurobiologist with interdisciplinary training in genomics, proteomics, and neuroscience. His research seeks to understand how cellular and synaptic diversity arises during human brain development and evolution, and how these same mechanisms may be hijacked in diseases such as brain cancer.
Li received his B.S. from Fudan University in China, where he studied synaptic plasticity during critical periods in the visual cortex. During his Ph.D. with Dr. Huda Zoghbi at Baylor College of Medicine, Li explored the molecular basis of neurodevelopmental disorders, uncovering how mutations in key proteins like SHANK3 and MeCP2 disrupt neural function. His postdoctoral work with Dr. Arnold Kriegstein at UCSF expanded this focus to human brain development at single-cell resolution. He generated multi-omic atlases and cross-species proteomic maps that revealed novel progenitor cell types and human-specific synapse maturation programs, with implications for cognition and brain cancer. Li directs the Human Brain Development Lab (https://www.liwanglab.org) at Stanford University, where he continues to investigate human brain development with a focus on stem cell lineages and synaptic diversity.
Li has received many awards, including the NIH K99/R00 Pathway to Independence Award, the Trainee Professional Development Award from the Society for Neuroscience, the Keystone Symposia Scholarship, the Dennis Weatherstone Predoctoral Fellowship from Autism Speaks, and the Dean’s Award for Excellence from Baylor College of Medicine.
